Bisphenol A and its analogues alter ERα/PR signaling, compromise decidualization, and disrupt the embryo–endometrium dialogue, contributing to impaired fetal growth, immune dysfunctions, and metabolic diseases. This evidence concerns the gene PGR and metabolic disease.